Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,54 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -34,92 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,51 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 41,35K | Nettoschuld 2015 | 19,86 mln. 18,25 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,60% | 364 mld. | |
+20,83% | 326 mld. | |
+5,69% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+10,77% | 167 mld. | |
+0,10% | 161 mld. |